Chemical Compound Review:
AC1L9LKM (2Z)-2-[ (3R,4R,8S,9S,10R,11R,13R,14S,1 6S)...
Synonyms:
- Fusidic acid resistance in Staphylococcus aureus isolates. Brown, E.M., Thomas, P. Lancet (2002)
- Inhibition of HIV replication in vitro by fusidic acid. Faber, V., Dalgleish, A.G., Newell, A., Malkovsky, M. Lancet (1987)
- Fusidic acid, HIV, and host cell toxicity. Richman, D.D., Mitsuya, H., Broder, S., Hostetler, K.Y. Lancet (1988)
- Delayed type hypersensitivity to fusidic acid in patients with chronic dermatitis. Riess, C.E., Bruckner-Tuderman, L. Lancet (1990)
- Granulocytopenia due to fusidic acid. Evans, D.I. Lancet (1988)
- Treatment of chronic endogenous uveitis with fusidic acid. Bendtzen, K., Vesti-Nielsen, N., Petersen, J., Andersen, V., Bendixen, G. Lancet (1991)
- Effect of bile salts and of fusidic acid on HIV-1 infection of cultured cells. Lloyd, G., Atkinson, T., Sutton, P.M. Lancet (1988)
- Post-termination complex disassembly by ribosome recycling factor, a functional tRNA mimic. Hirokawa, G., Kiel, M.C., Muto, A., Selmer, M., Raj, V.S., Liljas, A., Igarashi, K., Kaji, H., Kaji, A. EMBO J. (2002)
- Transcriptional termination at a fully rho-independent site in Escherichia coli is prevented by uninterrupted translation of the nascent RNA. Wright, J.J., Hayward, R.S. EMBO J. (1987)
- Release of ribosome-bound ribosome recycling factor by elongation factor G. Kiel, M.C., Raj, V.S., Kaji, H., Kaji, A. J. Biol. Chem. (2003)
- Outer membranes of gram-negative bacteria are permeable to steroid probes. Plésiat, P., Nikaido, H. Mol. Microbiol. (1992)
- Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. O'Neill, A.J., Chopra, I. Mol. Microbiol. (2006)
- Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Fantin, B., Leclercq, R., Duval, J., Carbon, C. Antimicrob. Agents Chemother. (1993)
- Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide. Hunter, P.R., George, R.C., Griffiths, J.W. Antimicrob. Agents Chemother. (1990)
- Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Parras, F., Guerrero, M.C., Bouza, E., Blázquez, M.J., Moreno, S., Menarguez, M.C., Cercenado, E. Antimicrob. Agents Chemother. (1995)
- Molecular analysis of fusidic acid resistance in Staphylococcus aureus. Besier, S., Ludwig, A., Brade, V., Wichelhaus, T.A. Mol. Microbiol. (2003)
- Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp. MacVanin, M., Johanson, U., Ehrenberg, M., Hughes, D. Mol. Microbiol. (2000)
- The effects of pure and micellar solutions of different bile salts on mucosal morphology in rat jejunum in vivo. Keeling, J.W., Lamabadusuriya, S.P., Harries, J.T. J. Pathol. (1976)
- Lack of activity of fusidic acid against human immunodeficiency virus in monocytes. Maehlen, T., Degré, M. Antimicrob. Agents Chemother. (1989)
- Effect of fusidic acid on the immune response in mice. Bellahsène, A., Forsgren, A. Infect. Immun. (1980)
- Interaction of fusidic acid with lipid membranes: Implications to the mechanism of antibiotic activity. Falck, E., Hautala, J.T., Karttunen, M., Kinnunen, P.K., Patra, M., Saaren-Seppälä, H., Vattulainen, I., Wiedmer, S.K., Holopainen, J.M. Biophys. J. (2006)
- The acid phosphatase with optimum pH of 2.5 of Escherichia coli. Physiological and Biochemical study. Dassa, E., Cahu, M., Desjoyaux-Cherel, B., Boquet, P.L. J. Biol. Chem. (1982)
- In vitro activity of ciprofloxacin against gram-positive cocci. Barry, A.L., Jones, R.N. Am. J. Med. (1987)
- Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Ward, A., Campoli-Richards, D.M. Drugs (1986)
- Escherichia coli susceptible to glycopeptide antibiotics. Shlaes, D.M., Shlaes, J.H., Davies, J., Williamson, R. Antimicrob. Agents Chemother. (1989)
- Antimicrobial Susceptibility Pattern of Clostridium difficile and Its Relation to PCR Ribotypes in a Swedish University Hospital. Aspevall, O., Lundberg, A., Burman, L.G., Akerlund, T., Svenungsson, B. Antimicrob. Agents Chemother. (2006)
- Sixteen homologs of the mex-type multidrug resistance efflux pump in Bacteroides fragilis. Ueda, O., Wexler, H.M., Hirai, K., Shibata, Y., Yoshimura, F., Fujimura, S. Antimicrob. Agents Chemother. (2005)
- Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101. O'Brien, F.G., Price, C., Grubb, W.B., Gustafson, J.E. J. Antimicrob. Chemother. (2002)
- The Neurospora crassa colonial temperature-sensitive 3 (cot-3) gene encodes protein elongation factor 2. Propheta, O., Vierula, J., Toporowski, P., Gorovits, R., Yarden, O. Mol. Gen. Genet. (2001)
- Effect of fusidic acid on the hepatic cytochrome P450 enzyme system. Reimann, G., Barthel, B., Rockstroh, J.K., Spatz, D., Brockmeyer, N.H. International journal of clinical pharmacology and therapeutics. (1999)
- Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats. Bendtzen, K., Diamant, M., Horn, T., Pedersen, C., Buschard, K. J. Endocrinol. (1992)
- Initiation factor IF2, thiostrepton and micrococcin prevent the binding of elongation factor G to the Escherichia coli ribosome. Cameron, D.M., Thompson, J., March, P.E., Dahlberg, A.E. J. Mol. Biol. (2002)
- Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid. Norén, T., Wullt, M., Akerlund, T., Bäck, E., Odenholt, I., Burman, L.G. Antimicrob. Agents Chemother. (2006)